NCT04138589View on ClinicalTrials.gov

Effect of Lumacaftor/Ivacaftor in Children With Cystic Fibrosis Homozygote for F508del on Small Airway Function

CompletedOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

November 1, 2017

Primary Completion Date

July 19, 2022

Study Completion Date

July 19, 2022

Conditions

Cystic Fibrosis in Children

Trial Locations (2)

Unknown

Children's Hospital Marien Hospital Wesel, Düsseldorf

Beatrix Children's Hospital, University Medical Center Groningen, Groningen

All Listed Sponsors

collaborator

Vertex Pharmaceuticals Incorporated

INDUSTRY

collaborator

Marien Hospital Wesel

OTHER

lead

University Medical Center Groningen

OTHER

NCT04138589 - Effect of Lumacaftor/Ivacaftor in Children With Cystic Fibrosis Homozygote for F508del on Small Airway Function | Biotech Hunter | Biotech Hunter